Global Markets
At Global Pharma Distributor (GPD), we operate on one consistent standard — regulated precision without borders.
From our MHRA-licensed UK facility, we manage GDP-compliant pharmaceutical exports for authorised partners across multiple continents, ensuring every delivery is traceable, verifiable, and compliant.
Our operations span markets in Africa, the Middle East, Asia, Latin America, and the Commonwealth, each governed by the same standards of GDP discipline and MHRA oversight.
Our presence isn’t defined by geography, but by integrity in every movement of medicine.
MHRA Licensed
GDP Compliant
WHO Aligned
EMA Standards
Licensed Distribution Across Regulated Markets
GPD’s international export framework supports both established and emerging healthcare systems under one uniform process: MHRA licensing, GDP documentation, and end-to-end temperature control.
Every consignment follows a verifiable chain of custody — from batch release to customs clearance — allowing our clients and regulators to confirm compliance without compromise.
Whether the shipment is bound for West Africa, the Gulf region, or the Pacific corridor, our role remains constant: deliver compliant pharmaceuticals with traceable documentation and validated quality.
Compliance in Practice, Not Promotion
We reference our regions, not to advertise reach, but to evidence governance.
Each operates under its own regulatory and climatic realities — all served through one common compliance structure.
Africa
GDP-aligned exports supporting regulated importers and institutional partners across diverse climates.
Middle East
Asia
Latin America
Commonwealth
Measured Delivery, Documented Assurance
We understand that in regulated trade, trust is earned through evidence.
Every export includes GDP verification, batch traceability, temperature logs, and export documentation conforming to MHRA and receiving-country requirements.
Our reputation rests on the quiet proof that every shipment leaves our facility legally documented, thermally stable, and audit-ready.
GDP Verification
Complete documentation for every shipment
Batch Traceability
Full chain of custody
tracking
Temperature Logs
Continuous cold-chain monitoring
Audit Ready
Compliant with MHRA
standards
Staying Current in an Evolving Landscape
Pharmaceutical legislation evolves constantly across the world’s regulatory bodies.
GPD maintains active alignment with MHRA, EMA, WHO, and equivalent national authorities to ensure uninterrupted compliance across all markets we serve.
We adapt our validation, documentation, and export processes as regulatory expectations develop — maintaining a living standard of compliance.
GDP-Compliant Solutions, Wherever They’re Needed
Whether supporting institutional tenders, managing temperature-sensitive shipments, or handling verified branded exports, GPD’s process remains unchanged — MHRA-licensed, GDP-certified, and documentation-led.
Frequently Asked Questions
What regulatory framework governs GPD's pharmaceutical exports?
GPD operates as an MHRA-licensed pharmaceutical wholesaler and exporter from a regulated UK facility located near London Heathrow. All pharmaceutical exports are prepared in accordance with Good Distribution Practice (GDP) requirements, ensuring documented chain of custody, batch traceability, and temperature monitoring throughout the export process (see our WHO prequalified medicine sourcing approach). This regulatory framework applies uniformly across all export corridors, regardless of destination market.
How does GPD maintain temperature stability for pharmaceutical exports to tropical regions?
Pharmaceutical consignments are prepared using validated packaging systems designed to maintain stable environmental conditions during international transit (aligned with our PEPFAR pharmaceutical distribution protocols). Temperature monitoring devices are incorporated into shipments where required, generating verifiable data that confirms environmental conditions experienced throughout the logistics journey. These monitoring records accompany each consignment, allowing authorised importers to verify temperature compliance from dispatch to arrival.
What documentation accompanies GPD pharmaceutical exports?
Export documentation typically includes GDP verification records, batch traceability documentation, temperature monitoring logs where applicable, certificate of analysis records, and export documentation conforming to both MHRA requirements and receiving-country regulatory standards. This documentation package enables authorised importers, pharmacy chains, hospital procurement teams, and licensed healthcare distributors to verify shipment preparation procedures and supports regulatory review by national health authorities. Documentation is prepared to align with GCC, African, and international regulatory frameworks.
Which regions does GPD export pharmaceuticals to?
How can authorised importers initiate pharmaceutical export coordination with GPD?
Authorised pharmaceutical importers, pharmacy chains, hospital procurement teams, and licensed healthcare distributors may contact GPD’s compliance office to discuss export preparation procedures, documentation requirements, and shipment coordination. Initial discussions typically cover product specifications, destination requirements, temperature sensitivity considerations, and documentation needed for regulatory clearance in the receiving country.